Year: 2021
Ocuphire Granted Two New U.S. Patents Covering Late-Stage Drug Candidate Nyxol®, Including for the Treatment of Presbyopia
Newly Issued Claims Extend Patent Protection to Year 2039 for Nyxol®Combination Therapy for Presbyopia […]
Pro-Dex, Inc (NASDAQ: PDEX)
Pro-Dex, Inc. specializes in the design, development, and manufacture of autoclavable, battery-powered and electric, multi-function surgical drivers and shavers used primarily in the orthopedic, thoracic, and maxocranial facial markets. We have patented adoptive torque-limiting software and proprietary sealing solutions which appeal to our customers, primarily medical device distributors. […]
Golden Independence Mining Corp. (CSE: IGLD) (OTCQB: GIDMF)
Interview with Christos Doulis, CEO
[…]
Entheon Biomedical Announces DMT Drug Supply Agreement with R&D Ofichem
Vancouver, British Columbia–(Newsfile Corp. – May 18, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, announced it […]
Video River Networks Reports Record Profit, EPS of $0.002 and P/E of 25.5 in Q1, 2021
Revenue up 34% and EPS up 4,391% to all-time record EPS of $0.002 and first profitable quarter in the Company’s most recent history […]
Entheon Biomedical Corp. Provides Corporate Update
Launch of Psychedelics DNA Test Kit,
Phase 1 clinical trial for DMT progressing as planned,
Pre-clinical In Vivo work scheduled to start at Israeli CRO […]
Entheon Biomedical Corp. Announces Participation in the Q2 Virtual Investor Summit
May 17th at 10:15 AM ET […]
ARCPACIFIC CUTS MASSIVE SULPHIDE MINERALIZATION WITHIN QUARTZ CARB VEIN IN HOLE 12 AT RICKARD GOLD PROJECT
All drill holes cut a wide interval (up to 90 meters overall in hole 11) containing zones of quartz carbonate veining with strong albite-sericite-silica alteration halos. […]
Video River Networks (OTC: NIHK)
Interview Franklin Igwealor, CEO
[…]